On another thread, someone suggested that "Canadian companies never make innovations", which is patently false. However, it is a common justification for using trade barriers to enforce inflated pharmaceutical prices in America. Just for example, here is an excerpt from the FIRST result of my google on the words "Canadian medical innovations". There were 104000 hits.
(from Nov. 15, 2000)
"Canadians may start seeing Cholesterol 1,2,3 tests in their doctor's office and pharmacy as early as this spring," said Dr. Brent Norton, President of IMI and a family physician. "The research presented at the AHA will form the basis of our submissions to both the Canadian Health Protection Branch and the American FDA."
"At the same time, we are continuing research to confirm that skin
cholesterol can be used to monitor a patient's response to cholesterol- lowering therapies used by hundreds of thousands of Canadians. That could also lead to a home version of the Cholesterol 1,2,3 test," said Dr. Norton.
IMI is a Canadian and world leader in predictive medicine, dedicated to developing innovative products for the rapid and early detection of life-threatening conditions, particularly cardiovascular disease and cancer. IMI is located in Toronto, with shares traded on the Toronto Stock Exchange
http://www.siliconinvestor.com/stocktalk/subject.gsp?subjectid=37417When do you suppose we will be seeing "Cholesterol 1,2,3" tests in innovative America?